Open AccessCombined lipid goal attainment in patients with type 2 diabetes and dyslipidemia: A head-to-head comparative trial of statins
Author(s) -
Tsung-Hui Wu,
I-Te Lee,
LowTone Ho,
Wayne HH Sheu,
ChiiMin Hwu
Publication year - 2022
Publication title -
journal of the chinese medical association
Language(s) - English
Resource type - Journals
eISSN - 1728-7731
pISSN - 1726-4901
DOI - 10.1097/jcma.0000000000000765
Subject(s) - medicine , simvastatin , dyslipidemia , rosuvastatin , type 2 diabetes , pitavastatin , statin , apolipoprotein b , triglyceride , endocrinology , diabetes mellitus , lipid profile , cholesterol , randomized controlled trial , gastroenterology
This study compared the efficacy of two statin treatments (simvastatin vs rosuvastatin) in achieving the combined goal of low-density lipoprotein cholesterol (LDL-C) <2.6 mmol/L and non-high-density lipoprotein cholesterol (non-HDL-C) <3.4 mmol/L in patients with type 2 diabetes and dyslipidemia.